|
Volumn 55, Issue 4, 2007, Pages 622-624
|
ALzheimer's disease medication: Use and cost projections for Medicare Part D [2]
a b c |
Author keywords
[No Author keywords available]
|
Indexed keywords
DONEPEZIL;
GALANTAMINE;
MEMANTINE;
RIVASTIGMINE;
TACRINE;
AGE DISTRIBUTION;
ALZHEIMER DISEASE;
BUDGET;
COST EFFECTIVENESS ANALYSIS;
DISEASE SEVERITY;
DRUG COST;
HEALTH CARE COST;
HUMAN;
LETTER;
MEDICAID;
PRESCRIPTION;
WORLD HEALTH ORGANIZATION;
AGED;
ALZHEIMER DISEASE;
FEE-FOR-SERVICE PLANS;
HUMANS;
MEDICAID;
NOOTROPIC AGENTS;
UNITED STATES;
|
EID: 33947634608
PISSN: 00028614
EISSN: 15325415
Source Type: Journal
DOI: 10.1111/j.1532-5415.2007.01106.x Document Type: Letter |
Times cited : (8)
|
References (9)
|